Case reports: nodular vasculitis responsive to mycophenolate mofetil.

Mycophenolate mofetil is commonly used as a steroid-sparing agent effective in the management of erythema nodosum, idiopathic nodular panniculitis (Pfiefer-Weber-Christian disease), bullous pemphigoid, pemphigus vulgaris, and psoriasis. We report a case of nodular vasculitis responsive to mycophenolate mofetil. The clinical presentation, etiology, and management options for nodular vasculitis are discussed.
AuthorsJosephine A Taverna, Arash Radfar, Alice Pentland, George Poggioli, Marie-France Demierre
JournalJournal of drugs in dermatology : JDD (J Drugs Dermatol) 2006 Nov-Dec Vol. 5 Issue 10 Pg. 992-3 ISSN: 1545-9616 [Print] United States
PMID17373149 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Dermatologic Agents
  • Immunosuppressive Agents
  • mycophenolate mofetil
  • Mycophenolic Acid
  • Aged
  • Dermatologic Agents (administration & dosage, therapeutic use)
  • Erythema Induratum (diagnosis, drug therapy)
  • Female
  • Humans
  • Immunosuppressive Agents (administration & dosage, therapeutic use)
  • Mycophenolic Acid (administration & dosage, analogs & derivatives, therapeutic use)
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: